- Home
- PET vs RLAY Comparison
PET vs RLAY Comparison
Compare PET & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PET
- RLAY
- Stock Information
- Founded
- PET 2015
- RLAY 2015
- Country
- PET United States
- RLAY United States
- Employees
- PET N/A
- RLAY N/A
- Industry
- PET EDP Services
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PET Technology
- RLAY Health Care
- Exchange
- PET Nasdaq
- RLAY Nasdaq
- Market Cap
- PET 5.9M
- RLAY 576.1M
- IPO Year
- PET N/A
- RLAY 2020
- Fundamental
- Price
- PET $0.17
- RLAY $3.63
- Analyst Decision
- PET Strong Buy
- RLAY Strong Buy
- Analyst Count
- PET 3
- RLAY 11
- Target Price
- PET $4.17
- RLAY $18.40
- AVG Volume (30 Days)
- PET 11.8M
- RLAY 1.6M
- Earning Date
- PET 08-06-2025
- RLAY 08-05-2025
- Dividend Yield
- PET N/A
- RLAY N/A
- EPS Growth
- PET N/A
- RLAY N/A
- EPS
- PET N/A
- RLAY N/A
- Revenue
- PET $62,453,000.00
- RLAY $7,679,000.00
- Revenue This Year
- PET $7.87
- RLAY $14.31
- Revenue Next Year
- PET $122.23
- RLAY N/A
- P/E Ratio
- PET N/A
- RLAY N/A
- Revenue Growth
- PET N/A
- RLAY N/A
- 52 Week Low
- PET $0.08
- RLAY $1.78
- 52 Week High
- PET $1.69
- RLAY $10.72
- Technical
- Relative Strength Index (RSI)
- PET 54.86
- RLAY 63.22
- Support Level
- PET $0.14
- RLAY $3.10
- Resistance Level
- PET $0.26
- RLAY $3.75
- Average True Range (ATR)
- PET 0.03
- RLAY 0.23
- MACD
- PET 0.01
- RLAY 0.03
- Stochastic Oscillator
- PET 43.90
- RLAY 84.42
About PET Wag! Group Co.
Wag Group Co develops and supports a proprietary marketplace technology platform available as a website and mobile app that enables independent Pet Caregivers to connect with pet parents. The platform allows pet parents to make pet service requests in the platform, which can then be fulfilled by Pet Caregivers. Wag supports dog walking, pet sitting, pet boarding, drop-in visits at the pet parent's home, advice from licensed pet experts, training services, pet insurance comparison tools and pet wellness plans.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).